1
Lammers, S W M, Meegdes, M, Vriens, I J H, Voogd, A C, de Munck, L, van Nijnatten, T J A, Keymeulen, K B M I, Tjan-Heijnen, V C G, Geurts, S M E
Veröffentlicht in: Lammers , S W M , Meegdes , M , Vriens , I J H , Voogd , A C , de Munck , L , van Nijnatten , T J A , Keymeulen , K B M I , Tjan-Heijnen , V C G & Geurts , S M E 2024 , ' Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands : a population-based retrospective cohort study ' , ESMO Open , vol. 9 , no. 5 , 103008 . https://doi.org/10.1016/j.esmoop.2024.103008;
2024
Veröffentlicht in: Lammers , S W M , Meegdes , M , Vriens , I J H , Voogd , A C , de Munck , L , van Nijnatten , T J A , Keymeulen , K B M I , Tjan-Heijnen , V C G & Geurts , S M E 2024 , ' Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands : a population-based retrospective cohort study ' , ESMO Open , vol. 9 , no. 5 , 103008 . https://doi.org/10.1016/j.esmoop.2024.103008;
2024
2
Lobbezoo, D.J.A., van Kampen, R.J.W., Voogd, A. C., Dercksen, M. W., van den Berkmortel, F., Smilde, T. J., van de Wouw, A. J., Peters, F. P. J., van Riel, J. M. G. H., Peters, N. A. J. B., de Boer, M., Peer, P. G. M., Tjan-Heijnen, V. C. G.
Veröffentlicht in: Lobbezoo , D J A , van Kampen , R J W , Voogd , A C , Dercksen , M W , van den Berkmortel , F , Smilde , T J , van de Wouw , A J , Peters , F P J , van Riel , J M G H , Peters , N A J B , de Boer , M , Peer , P G M & Tjan-Heijnen , V C G 2016 , ' In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium ' , Annals of Oncology , vol. 27 , no. 2 , pp. 256-262 . https://doi.org/10.1093/annonc/mdv544;
2016
Veröffentlicht in: Lobbezoo , D J A , van Kampen , R J W , Voogd , A C , Dercksen , M W , van den Berkmortel , F , Smilde , T J , van de Wouw , A J , Peters , F P J , van Riel , J M G H , Peters , N A J B , de Boer , M , Peer , P G M & Tjan-Heijnen , V C G 2016 , ' In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium ' , Annals of Oncology , vol. 27 , no. 2 , pp. 256-262 . https://doi.org/10.1093/annonc/mdv544;
2016
3
4
5